Drugs / 4-peptide melanoma vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00515528 | Apr 2007 → Mar 2016 | melanoma | University of Chicago | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4-peptide melanoma vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00515528 ↗ |
| Modality | Vaccine | “Experimental cancer vaccine given as a shot under the skin once every two weeks” NCT00515528 ↗ |
| Route | Subcutaneous | “injected intra-dermally or subcutaneously on day 1” NCT00515528 ↗ |